| Structure | Chemical Name | CAS | MF |
|
JNJ-632
|
1572510-42-9
|
C18H19FN2O4S
|
|
AB-423
|
1572510-80-5
|
C17H17F3N2O3S
|
|
Teneligliptin Hydrobromide Hydrate
|
1572583-29-9
|
C22H33BrN6O2S
|
|
Fmoc-Gln(Trt)-Thr(psime,mepro)-OH
|
1572725-72-4
|
C46H45N3O7
|
|
2-((4-methoxynaphthalen-2-yl)amino)-5-nitrobenzoic acid
|
1572936-83-4
|
C18H14N2O5
|
|
Tezepelumab
|
1572943-04-4
|
|
|
[1,1'-Biphenyl]-4-ethanol, α-(chloromethyl)-, (αS)-
|
1573000-28-8
|
C15H15ClO
|
|
[1,1'-Biphenyl]-4-propanol, β-amino-, (βR)- (hydrochloride)
|
1573000-33-5
|
C15H18ClNO
|
|
THK-523
|
1573029-17-0
|
C17H15FN2O
|
|
1-Methyl-3-nitro-5-trifluoroMethyl-1H-pyridin-2-one
|
1573056-08-2
|
C7H5F3N2O3
|
|
(3R)-azepan-3-ol
|
1573085-99-0
|
C6H13NO
|
|
Sp-8-bromo-Cyclic AMPS (sodium salt)
|
1573115-90-8
|
C10H12BrN5NaO5PS
|
|
1573118-33-8
|
1573118-33-8
|
C34H32N8O4
|
|
|
Lactonic Sophorolipid
|
1573124-58-9
|
|
|
5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole
|
1573171-39-7
|
C10H14BF3N2O2
|
|
N2,N2',N7,N7'-Tetrakis(3-Methoxyphenyl)-N2,N2',N7,N7'-tetrakis(4-Methoxyphenyl)-9,9'-spirobi[fluorene]-2,2',7,7'-tetraaMine
|
1573202-44-4
|
C81H68N4O8
|
|
N-Methyl-1-(3-methyl-1,2,4-oxadiazol-5-yl)methanamine hydrochloride
|
1573547-16-6
|
C5H10ClN3O
|
|
4-bromo-1-ethyl-3-phenyl-1H-pyrazole-5-carboxylic acid
|
1573547-18-8
|
C12H11BrN2O2
|
|
5-amino-2-isobutyrylisoxazol-3(2H)-one
|
1573547-19-9
|
C7H10N2O3
|
|
methyl 3-(3-mercapto-1H-1,2,4-triazol-5-yl)propanoate
|
1573547-21-3
|
C6H9N3O2S
|
|
[4-(1H-pyrrol-1-yl)tetrahydro-2H-thiopyran-4-yl]acetic acid
|
1573547-22-4
|
C11H15NO2S
|
|
2-Amino-N-(1-isopropyl-1H-pyrazol-5-yl)acetamide dihydrochloride
|
1573547-23-5
|
C8H15ClN4O
|
|
(7,8-Dimethoxy-2-oxo-1,2-dihydro-3H-3-benzazepin-3-yl)acetic acid
|
1573547-27-9
|
C14H15NO5
|
|
3-chloro-1-(methoxymethyl)-1H-1,2,4-triazole
|
1573547-46-2
|
C4H6ClN3O
|
|
3-(2-Methyl-4-oxo-1,4-dihydropyrimido[1,2-b]indazol-3-yl)propanoic acid
|
1573547-48-4
|
C14H13N3O3
|
|
5-amino-2-(3-methylbutanoyl)isoxazol-3(2H)-one
|
1573547-55-3
|
C8H12N2O3
|
|
3-bromo-5-methoxy-1-(methoxymethyl)-1H-1,2,4-triazole
|
1573547-56-4
|
C5H8BrN3O2
|
|
N-[(5-chloro-1H-1,2,4-triazol-3-yl)methyl]benzamide
|
1573547-59-7
|
C10H9ClN4O
|
|
1-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]piperazine hydrochloride
|
1573547-65-5
|
C8H15ClN4O2S
|
|
1-allyl-5-chloro-1H-1,2,4-triazole
|
1573547-66-6
|
C5H6ClN3
|
|
(3-((Phenylsulfonyl)methyl)-1,2,4-oxadiazol-5-yl)methanamine hydrochloride
|
1573547-68-8
|
C10H12ClN3O3S
|
|
5-(2-Phenylethyl)-2-(1H-pyrrol-1-yl)-1,3-thiazole-4-carboxylic acid
|
1573547-70-2
|
C16H14N2O2S
|
|
1-(3-Isopropyl-1,2,4-oxadiazol-5-yl)-N-methylmethanamine hydrochloride
|
1573547-75-7
|
C7H14ClN3O
|
|
[4-(1H-Pyrrol-1-yl)tetrahydro-2H-pyran-4-yl]acetic acid
|
1573547-77-9
|
C11H15NO3
|
|
2-acetyl-5-aminoisoxazol-3(2H)-one
|
1573547-89-3
|
C5H6N2O3
|
|
4-Amino-N-(1-isopropyl-1H-pyrazol-5-yl)butanamide dihydrochloride
|
1573547-94-0
|
C10H20Cl2N4O
|
|
3-(Methylthio)-1-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-1-amine hydrochloride
|
1573547-96-2
|
C12H16ClN3OS
|
|
3-((2-amino-9H-purin-6-yl)amino)propanoic acid
|
1573548-09-0
|
C8H10N6O2
|
|
4-Amino-N-(3-methylisoxazol-5-yl)butanamide hydrochloride
|
1573548-12-5
|
C8H14ClN3O2
|
|
(2-amino-2-adamantyl)acetic acid
|
1573548-14-7
|
C12H19NO2
|
|
3-Tetrazol-1-yl-3-thiophen-3-yl-propionic acid
|
1573548-25-0
|
C8H8N4O2S
|
|
2-(4-acetamido-1H-indol-1-yl)acetic acid
|
1573548-32-9
|
C12H12N2O3
|
|
1-(3-Methyl-1,2,4-oxadiazol-5-yl)-3-(methylthio)propan-1-amine hydrochloride
|
1573548-41-0
|
C7H14ClN3OS
|
|
(1-methoxycyclopropyl)methanamine hydrochloride
|
1574118-00-5
|
C5H12ClNO
|
|
9H-Fluoren-2-amine, N-[1,1'-biphenyl]-2-yl-N-(9,9-dimethyl-9H-fluoren-2-yl)-9,9-diphenyl-
|
1574121-95-1
|
C52H39N
|
|
BTO26-2ThBr
|
1574242-52-6
|
C30H38Br2N2O2S3
|
|
1,3,6,9,12-Pentaoxa-2-thiacyclotetradecane, 2,2-dioxide
|
1574267-61-0
|
C8H16O7S
|
|
4-Oxazolemethanol, 2-[4-(difluoromethoxy)-3-(1-methylethoxy)phenyl]-
|
1574285-36-1
|
C14H15F2NO4
|
|
(2-(4-(difluoromethoxy)-3-isopropoxyphenyl)oxazol-4-yl)methanamine hydrochloride
|
1574285-43-0
|
C14H17ClF2N2O3
|
|
Benzamide, 4-(difluoromethoxy)-3-(1-methylethoxy)-
|
1574285-91-8
|
C11H13F2NO3
|
|
2-(6-fluoro-2-methyl-4-oxoquinazolin-3(4H)-yl)-N-(2-hydroxyethyl)acetamide
|
1574321-43-9
|
C13H14FN3O3
|
|
Gon-5-en-3-one, 13-ethyl-17-hydroxy-11-methylene-, cyclic 1,2-ethanediylacetal
|
1574323-08-2
|
C22H32O3
|
|
2-(6-fluoro-2-methyl-4-oxoquinazolin-3(4H)-yl)-N-[(1,3,5-trimethyl-1H-pyrazol-4-yl)methyl]acetamide
|
1574324-64-3
|
C18H20FN5O2
|
|
Carbamic acid, N-(2,5-dibromo-4-pyridinyl)-, 1,1-dimethylethyl ester
|
1574395-46-2
|
C10H12Br2N2O2
|
|
7-Bromo-1,6-naphthyridin-2(1H)-one
|
1574395-48-4
|
C8H5BrN2O
|
|
7-fluoro-1,6-naphthyridine-2-carboxylic acid
|
1574395-52-0
|
C9H5FN2O2
|
|
(2S)-2-Amino-2-(4-chloro-3-fluorophenyl)ethan-1-ol hydrochloride
|
1574401-74-3
|
C8H10Cl2FNO
|
|
Ethyl 6-(Difluoromethyl)Nicotinate
|
1574401-80-1
|
C9H9F2NO2
|
|
2-(6-fluoro-2-methyl-4-oxoquinazolin-3(4H)-yl)-N-(pyridin-2-ylmethyl)acetamide
|
1574410-88-0
|
C17H15FN4O2
|
|
8-(4-Methoxy-phenyl)-1,5,8a,9-tetraaza-fluorene-6-carboxylic acid
|
1574411-07-6
|
C17H12N4O3
|
|
2-(6-fluoro-2-methyl-4-oxoquinazolin-3(4H)-yl)-N-(pyridin-4-ylmethyl)acetamide
|
1574485-27-0
|
C17H15FN4O2
|
|
(1S,2R,3S,4R)-2-((E)-5-(Benzyloxy)pent-2-en-1-yl)-3-(((tert-butyldimethylsilyl)oxy)methyl)-4-((tetrahydro-2H-pyran-2-yl)oxy)cyclopentanol
|
1574525-15-7
|
C29H48O5Si
|
|
(1S,2R,3S,4R)-2-((E)-5-(benzyloxy)pent-2-en-1-yl)-3-(((tert-butyldimethylsilyl)oxy)methyl)-4-((tetrahydro-2H-pyran-2-yl)oxy)cyclopentyl acetate
|
1574525-20-4
|
C31H50O6Si
|
|
(1S,2R,3S,4R)-3-(((tert-Butyldimethylsilyl)oxy)methyl)-2-(5-hydroxypentyl)-4-((tetrahydro-2H-pyran-2-yl)oxy)cyclopentyl acetate
|
1574525-21-5
|
C24H46O6Si
|
|
(1S,2R,3S,4R)-3-(((tert-Butyldimethylsilyl)oxy)methyl)-2-(5-oxopentyl)-4-((tetrahydro-2H-pyran-2-yl)oxy)cyclopentyl acetate
|
1574525-26-0
|
C24H44O6Si
|
|
Lurasidone Impurity
|
1574569-32-6
|
C28H36N4O3S
|
|
(OC-6-42)-Bis[[2,3-butanedione 2,3-di(oximato-κN)](1-)]chloro(4-methoxypyridine-κN)cobalt
|
1574577-65-3
|
C14H21ClCoN5O5
|
|
α-D-Glucopyranose, O-6-O-acetyl-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-D-glucopyranosyl-(1→4)-O-6-methyl-2,3-bis-O-(phenylmethyl)-β-D-glucopyra
|
1574590-12-7
|
C53H60N6O18
|
|
(4aS,8aS,9S)-3-(benzyloxy)-4a-((tert-butyldimethylsilyl)oxy)-9-(diethylamino)-8a,9-dihydronaphtho[2,3-d]isoxazole-4,5(4aH,8H)-dione
|
1575491-01-8
|
C28H38N2O5Si
|
|
phenyl 6-(benzyloxy)-4-(1-benzylpyrrolidin-2-yl)-2-methyl-3-(trifluoromethyl)benzoate
|
1575494-29-9
|
C33H30F3NO3
|
|
2-methyl-2-[methyl(oxetan-3-yl)amino]propanal
|
1575589-84-2
|
C8H15NO2
|
|
tert-butyl 2,6-dimethylpiperazine-1-carboxylate, cis
|
1575591-48-8
|
C11H22N2O2
|
|
PRN-1008
|
1575591-66-0
|
C36H40FN9O3
|
|
2-methyl-2-(4-oxetan-3-yl-piperazin-1-yl)-propionaldehyde
|
1575591-71-7
|
C11H20N2O2
|
|
PRN1008
|
1575596-29-0
|
C36H40FN9O3
|
|
3-bromo-4,5,6,7-tetrahydro-[1,2,3]triazolo[1,5-a]pyrazine
|
1575612-75-7
|
C5H7BrN4
|
|
2-Bromo-5,6-dihydro-8H-[1,2,4]triazolo[1,5-a]pyrazine-7-carboxylic acid tert-butyl ester
|
1575613-02-3
|
C10H15BrN4O2
|
|
1575672-58-0
|
1575672-58-0
|
C42H46O23
|
|
PRN694
|
1575818-46-0
|
C28H35F2N5O2S
|
|
Spiro[azetidine-3,7'(5'H)-furo[3,4-b]pyridine]-1-carboxylic acid, 3'-bromo-, 1,1-dimethylethyl ester
|
1575836-59-7
|
C14H17BrN2O3
|
|
2-Bromomethyl-6-chloro-3-iodo-pyridine
|
1575836-78-0
|
C6H4BrClIN
|
|
1-Boc-6’-chloro-1’H-spiro[azetidine-3,3’-furo[3,4-c]pyridine
|
1575836-95-1
|
C14H17ClN2O3
|
|
4-Bromomethyl-2-chloro-5-iodo-pyridine
|
1575836-97-3
|
C6H4BrClIN
|
|
(2-Chloro-5-iodo-pyridin-4-yl)-methanol
|
1575836-99-5
|
C6H5ClINO
|
|
1-Butanone, 4-[(6bR,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-1-phenyl-
|
1576239-82-1
|
C24H29N3O
|
|
6-Bromo-5-methoxy-1-methyl-1H-indazole
|
1577179-97-5
|
C9H9BrN2O
|
|
N-(4-((6-bromo-1-methyl-1H-indazol-5-yl)oxy)-3-fluorophenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide
|
1577180-07-4
|
C27H19BrF2N4O3
|
|
4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate
|
1577222-14-0
|
C11H13NO6
|
|
SnAP OA Reagent
|
1577233-70-5
|
C16H37NOSn
|
|
SnAP DA Reagent
|
1577233-73-8
|
C21H46N2O2Sn
|
|
4-[(Tributylstannyl)methoxy]-1-butanamine
|
1577233-75-0
|
C17H39NOSn
|
|
4-[(AMidinothio)Methyl]styrene hydrochloride
|
1577250-09-9
|
C32H37ClN2O2S
|
|
(E)-3-(dimethylamino)-2-(pyridin-2-yl)acrylonitrile
|
1577254-94-4
|
C10H11N3
|
|
Rucaparib Impurity 5
|
1577982-06-9
|
C17H13FN2O
|
|
Rucaparib Impurity 3
|
1577983-65-3
|
C18H15FN2O2
|
|
Desmethyl Rucaparib
|
1577983-73-3
|
C18H16FN3O
|
|
Rucaparib Carboxylic Acid
|
1577998-89-0
|
C18H13FN2O3
|
|
Rucaparib Impurity 1
|
1577999-02-0
|
C19H16FN3O2
|
|
RO6889678
|
1578153-27-1
|
C21H20ClFN4O5S
|
|
2-Bromo-3,4-difluorobenzyl alcohol
|
1578156-19-0
|
C7H5BrF2O
|